Cerulean Pharma, Inc

Cerulean Pharma, Inc

Cerulean Pharma, Inc

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Founded
2006
Raised
$122.2M
Follow us
Alexa global traffic share
Latest funding Show all
$35,000,000
Post-IPO equity - 2015
$26,000,000
Debt financing - 2015
Team Size
10+
Employees
Xconomy

Cerulean's Shares Routed as Cancer Drug Comes up Short Again

Health